Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Panel of congenital disorders of glycosylation. NGS panel of 47 genes. Genologica Medica Spain | 55 | 47 |
|
ALG3 Gene Sequencing by Massively Parallel Sequencing (BCM-NGSSM) Baylor Genetics United States | 1 | 1 |
|
ALG3 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
ALG3 Sequence Analysis (Prenatal Sequence Analysis) Baylor Genetics United States | 1 | 1 |
|
Congenital Disorders of Glycosylation Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 51 | 41 |
|
Congenital Disorders of Glycolysation Asper Biogene Asper Biogene LLC Estonia | 53 | 49 |
|
Congenital disorders of glycosylation, type I: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 26 | 26 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Fulgent Genetics United States | 509 | 275 |
|
Congenital Disorders of Glycosylation, Panel Massive Sequencing (NGS) 30 Genes Reference Laboratory Genetics Spain | 30 | 30 |
|
CONGENITAL DISORDERS OF GLYCOSYLATION Laboratorio de Genetica Clinica SL Spain | 5 | 5 |
|
Congenital Disorder of Glycosylation Type ID , Sequencing ALG3 Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Asper Biogene Asper Biogene LLC Estonia | 210 | 204 |
|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
CeGaT GmbH Germany | 1 | 1 |
|
Congenital Disorders of Glycosylation (CDG) MGZ Medical Genetics Center Germany | 4 | 38 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Fulgent Genetics United States | 1103 | 676 |
|
Intellectual Disability NGS Panel Fulgent Genetics United States | 1058 | 554 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.